Visterra, Inc. — Form D/A
Visterra, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2013-12-02. The offering totals $34.2M, of which $34.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-12-02
- Form: D/A
- Accession: 0001426375-13-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $34.2M
- Amount sold: $34.2M
- Investors: 16
- Date of first sale: 2012-05-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-178849
Issuer
- Name: Visterra, Inc.
- CIK: 0001426375
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: (617) 498-1070
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Kevin JG Bitterman | Director | Cambridge, MA |
| Alan JG Crane | Director | Cambridge, MA |
| Edward JG Kania | Director | Cambridge, MA |
| Brian JG Pereira, M.D. | Director | Cambridge, MA |
| Ram JG Sasisekharan | Director | Cambridge, MA |
| David JG Arkowitz | Executive Officer | Cambridge, MA |
| Brian JG Pereira, M.D. | Executive Officer | Cambridge, MA |
| Kevin Bitterman | Director | Cambridge, MA |
| Kevin Bitterman | Executive Officer | Cambridge, MA |
| Alan Crane | Director | Watertown, MA |
| Steven Brugger | Director | Cambridge, MA |
| Steven Brugger | Executive Officer | Cambridge, MA |
| Edward Kania | Director | Lexington, MA |
| Ram Sasisekharan | Director | Cambridge, MA |
Other filings by this issuer (4)
More